Peg interferon alpha-2b
P04371
Phase 3 small_molecule terminated
Quick answer
Peg interferon alpha-2b for Hepatitis C is a Phase 3 program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Hepatitis C
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated